Number of the records: 1
naltrexón
SYS d009271 LBL 00000cz--a2200000o--4500 005 20250606214509.4 008 920723|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D03.132.577.249.706.550 065 $a D03.605.497.750.550 065 $a D03.633.400.686.750.550 065 $a D04.615.723.795.706.550 066 $a 01 $c 03 150 $a naltrexón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000427 $Y Alcohol Deterrents $w P $a prípravky na odvykanie od alkoholu 550 $7 sllk_us_auth*d009292 $Y Narcotic Antagonists $w P $a antagonisty narkotík 665 $a 1986 (1976) $2 eng 665 $a Cyclopropanes (1973-1975) $2 eng 665 $a Morphinans (1973-1974) $2 eng 665 $a Naloxone/analogs & derivatives (1975) $2 eng 680 9-
$i Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. $2 eng 750 -2
$a Naltrexone $2 eng 980 $x M
Number of the records: 1